Azd 0156 is an orally bioavailable, potent and selective inhibitor of ataxia telangiectasia mutated (ATM) kinase, a serine/threonine protein kinase involved in DNA damage response. It is based on an imidazo[4,5-c]quinolin-2-one core and is used in research as a laboratory reagent to study ATM-mediated signaling and DNA repair.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1821428-35-6
Rupatadine fumarate
pharmaceutical raw material
1-demethyl-4,5-dihydrodiazepam
pharmaceutical raw material
Oxazepam acetate
pharmaceutical raw material
Raloxifene 4'-glucuronide
pharmaceutical raw material
8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one
AOTRIQLYUAFVSC-UHFFFAOYSA-N
CN1C2=CN=C3C=CC(=CC3=C2N(C1=O)C4CCOCC4)C5=CN=C(C=C5)OCCCN(C)C